fda duloxetine news - Search News

FDA, bottles of Duloxetine

FDA Has Recalled Thousands of Bottles of Antidepressant Duloxetine, Sold Under Brand Name Cymbalta: Here’s Why

The Duloxetine Delayed-Release Capsules' voluntary recall began on Oct. 10 after the FDA deemed the medication the second-highest risk classification. Over 7,100 bottles of Duloxetine were recalled, including 500 delayed-release 20mg capsules. The lot number is 220128, and the expiration date is 12/2024, per the FDA report.

New York Post on MSN · 2h

Thousands of bottles of common antidepressant Cymbalta recalled by FDA over cancer-causing chemical

Thousands of bottles of a commonly prescribed antidepressant drug were recalled because they contained a suspected cancer-causing chemical.

MLive · 16h

7,100 bottles of antidepressant recalled by FDA now in 2nd highest risk class

Duloxetine Delayed-Release Capsules were recalled because the pills may contain high levels of a cancer-causing chemical.

39m

Antidepressants recalled over cancer-causing chemical; should you stop taking your pills?

The FDA recalled thousands of bottles of antidepressants after finding high levels of potentially cancer-causing chemicals. Here's what to look for.

This antidepressant is being recalled: Here’s why

The U.S. Food and Drug Administration (FDA) has issued a nationwide recall of thousands of bottles of antidepressants. These ...

Newsweek4d

Nationwide Antidepressant Recall Update As FDA Sets Risk Class

The recall of the Duloxetine Delayed-Release Capsules, produced by Towa Pharmaceutical Europe, was initiated on October 10 and has been given the second highest risk classification by the FDA.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

FDA, bottles of Duloxetine

Related topics